Review Article | Published:

Inhibitors of Angiogenesis

Bio/Technologyvolume 9pages630634 (1991) | Download Citation



Angiogenesis, the formation of new capillaries, is essential to a number of important physiological events, both normal and pathological. Recently, increased attention has focused on the purification and characterization of inhibitors of this process, because of the potential therapeutic value of angiogenesis inhibitors in controlling such “angiogenic diseases” as proliferative retinopathy, solid tumors, rheumatoid arthritis, and neovascular glaucoma. We review the process of neovascularization and the assays that have been developed to study its inhibition in vivo and in vitro. We also discuss the properties of different angiogenesis inhibitors and examine the mechanisms by which such inhibitors could potentially intervene in the process of neovascularization.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Hobson, B. and Denekamp, J. 1984. Endothelial proliferation in tumours and normal tissues: Continuous labelling studies. Br. J. Cancer 49: 405–413.

  2. 2

    Folkman, J. and Klagsbrun, M. 1987. Angiogenic factors. Science 235: 442–447.

  3. 3

    Waltman, D.D., Gitter, K.A., Yannuzzi, L. and Schatz, H. 1978. Choroidal neovascularization associated with choroidal nevi. Am. J. Ophthal. 85: 704–710.

  4. 4

    Gartner, S., Henkind, P. 1978. Neovascularization of the iris (rubeosis iridis). Surv. Ophthal. 22: 291–312.

  5. 5

    Klagsbrun, M. and D'Amore, P.A. 1991. Regulators of angiogenesis. Ann. Rev. Physiol. 53: 217–223.

  6. 6

    Gimbrone, M.A., Leapman, S.B., Cotran, R.S. and Folkman, J. 1972. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 136: 261–276.

  7. 7

    Blood, C.H. and Zetter, B.R. 1990. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim et Biophys Acta 1032: 89–118.

  8. 8

    Langer, R. and Murray, J. 1983. Angiogenesis inhibitors and their delivery systems. Appl. Biochem. and Biotech. 8: 7–24.

  9. 9

    Langer, R. and Folkman, J. 1976. Polymers for the sustained release of proteins and other macromolecules. Nature 263: 797–800.

  10. 10

    Langer, R., Brem, H., Falterman, K., Klein, M. and Folkman, J. 1976. Isolation of a cartilage factor that inhibits tumor neovascularization. Science 193: 70–72.

  11. 11

    Moses, M.A., Sudhalter, J. and Langer, R. 1990. Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408–1410.

  12. 12

    Folkman, J., Haudenschild, C. and Zetter, B.R. 1979. Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. USA. 76: 5217–5221.

  13. 13

    Ausprunk, D.H. and Folkman, J. 1977. Migration and proliferation of endothelial cells in preformed and newly formed vessels during tumor angiogenesis. Microvasc. Res. 14: 53–165.

  14. 14

    Connelly, D.T., Knight, M.B., Marakas, N.K., Wittwer, A.J. and Fader, J. 1986. Determination of the number of endothelial cells in culture using an acid phosphatase assay. Analyt. Biochem. 152: 136– 140.

  15. 15

    Falk, W., Goodwin, H. and Leonard, J. 1980. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. 118: 239–247.

  16. 16

    Boyden, S. 1962. Chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J. Exptl. Med. 115: 453–456.

  17. 17

    Glaser, B.M., D'Amore, P.A., Seppa, H., Seppa, E. and Schifferman, E. 1980. Adult tissues contain chemoattractants for vascular endothelial cells. Nature 280: 483–484.

  18. 18

    Eisenstein, R., Kuettner, K.E., Neopolitan, C., Soble, L.W. and Sorgente, N. 1975. The resistance of certain tissue to invasion III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture. Am. J. Pathol. 81: 337–347.

  19. 19

    Pauli, B., Memoli, V. and Kuettner, K. 1981. Regulation of tumor invasion by cartilage-derived anti-invasion factor in vitro. J. Natl. Cancer Inst. 67: 65–73.

  20. 20

    Brem, H. and Folkman, J. 1975. Inhibition of tumor angiogenesis mediated by cartilage. J. Exp. Med. 141: 427–439.

  21. 21

    Lee, A. and Langer, R. 1983. Shark cartilage contains inhibitors of tumor angiogenesis. Science 221: 1185–1187.

  22. 22

    Langer, R., Conn, H., Vacanti, J., Haudenschild, C. and Folkman, J. 1980. Control of tumor growth in animals by infusion of an angiogenesis inhibitor. Proc. Natl. Acad. Sci. USA. 77: 4331–4335.

  23. 23

    Rifkin, D.B., Gross, S.L., Moscatelli, D. and Jaffe, E. 1982. Proteases and angiogenesis: Production of plasminogen activator and collagenase by endothelial cells, p. 191–197. Pathobiology of the Endothelial Cell. Nossel, M. L. and Vogel, H. J. (Eds). Academic Press, New York.

  24. 24

    Liotta, L.A., Tryggvason, S., Garbisa, S., Hart, I., Foltz, C.M. and Shafie, S. 1980. Metastic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67–68.

  25. 25

    Khokha, R., Waterhouse, P., Yagel, S., Lala, P.K., Overall, G.M., Norton, G. and Denhardt, D.T. 1989. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity in Swiss 3T3 cells. Science 243: 947–950.

  26. 26

    Lutty, G.A., Thompson, D.C., Gallup, J.Y., Mello, R.J., Patz, A. and Fenselau, A. 1983. Vitreous: an inhibitor of retinal extract-induced neovascularization. Invest. Ophthalmol. Vis. Sci. 24: 52–56.

  27. 27

    Brem, S., Preis, I., Langer, R., Folkman, J. and Patz, A. 1977. Inhibition of neovascularization by an extract derived from vitreous. Am. J. Ophthalmol. 84: 323–328.

  28. 28

    Williams, G.A., Eisenstein, R., Schumacher, B., Hsiao, K.C. and Grant, D. 1984. Inhibitor of vascular endothelial cell growth in the lens. Am. J. Ophthalmol. 97: 366–371.

  29. 29

    Mun, E.C., Doctrow, S.R., Carter, R., Ingber, D.E. and Folkman, J. 1989. An angiogenesis inhibitor from the cornea. Invest. Ophthalmol. Vis. Sci. 30: 151.

  30. 30

    Folkman, J., Langer, R., Linhardt, R.J., Haudenschild, C. and Taylor, S. 1983. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221: 719–725.

  31. 31

    Crum, R., Szabo, S. and Folkman, J. 1985. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375–1378.

  32. 32

    Folkman, J., Weisz, P.B., Joullie, M.M., Li, W.W. and Ewing, W.R. 1989. Control of angiogenesis with synthetic heparin substitutes. Science 243: 1490–1493.

  33. 33

    Taylor, S. and Folkman, J. 1982. Protamine is an inhibitor of angiogenesis. Nature 297: 307–312.

  34. 34

    Maione, T.E., Gray, G.S., Petro, J., Hunt, A.J., Donner, A.L., Bauer, S.I., Carson, H.F. and Sharpe, R.J. 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247: 77–79.

  35. 35

    Sharpe, R.J., Byers, H.R., Scott, C.F., Bauer, S.I. and Maione, T.E. 1990. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor-4. J. Natl. Cancer Inst. 82: 848–853.

  36. 36

    Good, D.J., Polverini, P.J., Rastinejad, F., LeBeau, M.M., Lemons, R.S., Frazier, W.A. and Bouck, N.P. 1990. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Nat. Acad. Sci. USA 87: 6624–6628.

  37. 37

    Rastinejad, F., Polverini, P.J. and Bouck, N.P. 1989. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56: 345–355.

  38. 38

    Frater-Schroeder, M., Risau, W., Hallman, R., Gautschi, R. and Bohlen, P. 1987. Tumor necrosis factor type-α, a potent inhibitor of endothelial cell growth in vitro, is angiogemc in vivo. Proc. Natl. Acad. Sci. USA. 84: 5277–5281.

  39. 39

    Muller, G., Behrens, J., Nussbaumer, U., Bohlen, P. and Birchmeier, W. 1987. Inhibitory action of transforming growth factor beta on endothelial cells. Proc. Natl. Acad. Sci. USA. 84: 5600–5604.

  40. 40

    Muthukkarauppan, V.R. and Auerbach, R. 1979. Angiogenesis in the mouse cornea. Science 205: 1416–1417.

  41. 41

    Orchard, P.J., Smith, C.M., II, Woods, W.G., Day, D.L., Dehner, L.P. and Shapiro, R. 1989. Treatment of haemangioendotheliomas with alpha interferon. The Lancet 2: 565–567.

  42. 42

    Friesel, R., Komoriya, A. and Maciag, T. 1987. Inhibition of endothelial cell proliferation by gamma-interferon. J. Cell Biol. 104: 689–690.

  43. 43

    Tamargo, R.S., Bok, R.A. and Brem, H. 1991. Angiogenesis inhibition by minocycline. Cancer Res. 51: 672–675.

  44. 44

    Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, K., Brem, H. and Folkman, J. 1990. Angioinhibins: Synthetic analogues of fumagillin which inhibit angiogenesis and suppress tumour growth. Nature 348: 555–557.

  45. 45

    Poole, T.S. and Zetter, B.R. 1989. Stimulation of rat peritoneal mast cell migration by tumor-derived peptides. Cancer Res. 43: 5857–5861.

  46. 46

    Azizkhan, R.G., Azizkhan, J.C., Zetter, B.R. and Folkman, J. 1980. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J. Exp. Med. 152: 931–944.

  47. 47

    Gospodarowicz, D. and Cheng, J. 1986. Heparin protects basic and acidic FGF from inactivation. J. Cell Physiol. 128: 475–484.

  48. 48

    Sakamoto, S., Goldhaber, P. and Glimcher, M.J. 1973. Mouse bone collagenase. The effect of heparin on the amount of enzyme released and on the activity of the enzyme. Calcif. Tissue Res. 12: 247–258.

  49. 49

    Ingber, D.E., Madri, J.A. and Folkman, J. 1986. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement dissolution. Endocrinology. 119: 1768–1775.

  50. 50

    Neufield, G. and Gospodarowicz, D. 1987. Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor. J. Cell Physiol. 132: 287–294.

  51. 51

    Klagsbrun, M. and Folkman, J. 1990. Angiogenesis. Handbook of Experimental Pharmacology, Vol., 95/11 Peptide Growth Factors and Their Receptors II, p. 549–586. M. B. Sporn and A. B. Roberts, (Eds.). Springer-Verlag, Berlin, Heidelberg, Germany.

Download references

Author information

Author notes

  1. Robert Langer: Corresponding author.


  1. Department of Surgery, The Children's Hospital Medical Center, Boston, MA, 02115

    • Marsha A. Moses
  2. Department of Chemical Engineering and Harvard-MIT, Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139

    • Robert Langer


  1. Search for Marsha A. Moses in:

  2. Search for Robert Langer in:

About this article

Publication history

Issue Date


Further reading